Dosage and administration
Apply a small amount to hands. Wash hands, rinse thoroughly with water, and repeat as necessary between patient contacts.
Apply a small amount to hands. Wash hands, rinse thoroughly with water, and repeat as necessary between patient contacts.
Drug Facts
0.75% Triclosan
Antiseptic
Healthcare Personnel Handwash to decrease transient bacteria on the skin before contact with patients under medical care or treatment.
For external use only
Discontinue use if irritation and redness develop. If irritation persists for more than 3 days, consult a physician.
When using this product do not get it in the eyes; causes eye irritation upon direct contact. In case of eye exposure, rinse thoroughly with water. If eye irritation persists, contact a physician.
Keep out of reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.
Apply a small amount to hands. Wash hands, rinse thoroughly with water, and repeat as necessary between patient contacts.
Water, Hexylene glycol, Propyl alcohol, Propylene glycol, Sorbitol, PEG-150 distearate, Sodium lauroyl methyl isethionate, PEG-45 palm kernel glycerides, PEG-7 glyceryl cocoate, C12-C15 alkyl benzoate, Ethanolamine lauroyl sarcosinate, Cocamide MEA, Diammonium EDTA, Citric acid, Ammonium lauryl sulfate, Ethanolamine, Fragrance
800-548-4873
Kindest Kare®
Antimicrobial
Foaming Handwash
NDC 0519-1452-41
Hand Soap
15
seconds
Fast-acting
Mild Fragrance
Antimicrobial
REORDER #
1452-FM
1 Liter FSDS (33.8 fl oz) (1.05 qt)
STERIS®
STERIS Corporation ◾ 7501 Page Avenue ◾ St. Louis, MO 63133 ◾ USA
800-548-4873 ◾
www.steris.com
1452-X7D(F)(1014)
62453

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| 424daadb-95de-8ece-97f5-235e3f7f0001 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0519-1452-87 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be78-f424-e053-dadaa90a57ce | Kindest Kare ® Antimicrobial Foaming Handwash Healthcare Personnel Handwash |
| 0519-1452-91 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be78-f424-e053-dadaa90a57ce | Kindest Kare ® Antimicrobial Foaming Handwash Healthcare Personnel Handwash |
| 0519-1452-92 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be78-f424-e053-dadaa90a57ce | Kindest Kare ® Antimicrobial Foaming Handwash Healthcare Personnel Handwash |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0519-1452-13 | Kindest Kare Antimicrobial Foaming Handwash Healthcare Personnel Handwash | 444 mL in 1 BOTTLE | LIQUID | 444 | 3 | |
| 0519-1452-41 | Kindest Kare Antimicrobial Foaming Handwash Healthcare Personnel Handwash | 1000 mL in 1 BOTTLE | LIQUID | 1000 | 3 | |
| 0519-1452-87 | Kindest Kare Antimicrobial Foaming Handwash Healthcare Personnel Handwash | 12 in 1 CASE | LIQUID | 12 | 3 | |
| 0519-1452-91 | Kindest Kare Antimicrobial Foaming Handwash Healthcare Personnel Handwash | 18 in 1 CASE | LIQUID | 18 | 3 | |
| 0519-1452-92 | Kindest Kare Antimicrobial Foaming Handwash Healthcare Personnel Handwash | 6 in 1 CASE | LIQUID | 6 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Triclosan | ACTIVE INGREDIENT | 4NM5039Y5X | 3 | |
| Triclosan | ACTIVE MOIETY | 4NM5039Y5X | 3 | |
| Alkyl (C12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 3 | |
| Ammonium lauryl sulfate | INACTIVE INGREDIENT | Q7AO2R1M0B | 3 | |
| Citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 3 | |
| Coco monoethanolamide | INACTIVE INGREDIENT | C80684146D | 3 | |
| Edetic Acid | INACTIVE INGREDIENT | 9G34HU7RV0 | 3 | |
| Hexylene glycol | INACTIVE INGREDIENT | KEH0A3F75J | 3 | |
| Lauroyl sarcosine | INACTIVE INGREDIENT | LIJ19P3L6F | 3 | |
| Monoethanolamine | INACTIVE INGREDIENT | 5KV86114PT | 3 | |
| PEG-150 distearate | INACTIVE INGREDIENT | 6F36Q0I0AC | 3 | |
| Peg-45 Palm Kernel Glycerides | INACTIVE INGREDIENT | UC117W498W | 3 | |
| PEG-7 glyceryl cocoate | INACTIVE INGREDIENT | VNX7251543 | 3 | |
| Propyl alcohol | INACTIVE INGREDIENT | 96F264O9SV | 3 | |
| Propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 3 | |
| sodium lauroyl methyl isethionate | INACTIVE INGREDIENT | II6VCD3S6R | 3 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | 3 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0519-1452 | 0519-1452-13, 0519-1452-91, 0519-1452-41, 0519-1452-92, 0519-1452-87 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO / TOPICAL | 8 %w/w | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / BUCCAL | 5110 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SYRUP / ORAL | 4370 mg/5ml | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| Edetic Acid | EDETIC ACID | 9G34HU7RV0 | TABLET / ORAL | 4 mg | ||
| Hexylene glycol | HEXYLENE GLYCOL | KEH0A3F75J | SOLUTION / TOPICAL | 0.3 %w/w | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TRANSDERMAL | 500 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / SUBCUTANEOUS | 4.7 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, SOLUTION / SUBCUTANEOUS | 4.7 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| Edetic Acid | EDETIC ACID | 9G34HU7RV0 | INJECTION, SOLUTION / INTRAVENOUS | 2 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | PASTE / DENTAL | 14.6 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, SOLUTION / INTRAVENOUS | 4050 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / NASAL | 25 mg/1ml | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | PASTE, DENTIFRICE / DENTAL | 14 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | CREAM, AUGMENTED / TOPICAL | 15 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / RECTAL | 46.18 %w/v | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| Propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| de18f0b8-6eb1-4750-917d-da97fe2d95fc | 4ec12f4d-6cb7-4154-8cf3-02d4bb8a6d9c | 2014-12-03 | Warnings | de18f0b8-6eb1-4750-917d-da97fe2d95fc 4ec12f4d-6cb7-4154-8cf3-02d4bb8a6d9c |
Adverse event summaries are temporarily unavailable. Other product information remains available.